6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis
- PMID: 2646222
6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis
Abstract
The role of immunosuppressives in the treatment of Crohn's disease and ulcerative colitis will be reviewed. This will include a comprehensive presentation of the uncontrolled and controlled studies in both diseases. The author's personal experiences with more than 400 patients will be summarized, including efficacy and short- and long-term toxicity. A review of the literature regarding the risk of superinfections and neoplasia will be presented. Finally, specific indications for the use of 6-MP/azathioprine will be listed.
Similar articles
-
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.Dan Med Bull. 2011 Dec;58(12):B4360. Dan Med Bull. 2011. PMID: 22142578
-
Current status of drug therapy for inflammatory bowel disease.Compr Ther. 1985 Dec;11(12):14-9. Compr Ther. 1985. PMID: 2866866 Review.
-
Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.Gastroenterologist. 1995 Jun;3(2):141-52. Gastroenterologist. 1995. PMID: 7640945 Review.
-
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.Am J Gastroenterol. 1993 Jan;88(1):44-8. Am J Gastroenterol. 1993. PMID: 8420272
-
The drug therapy of ulcerative colitis and of Crohn's disease.Semin Drug Treat. 1974 Spring;3(4):339-49. Semin Drug Treat. 1974. PMID: 4150770 No abstract available.
Cited by
-
Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity.Dig Dis Sci. 1994 Aug;39(8):1638-41. doi: 10.1007/BF02087769. Dig Dis Sci. 1994. PMID: 8050312
-
Monitoring thiopurine metabolites in inflammatory bowel disease.Frontline Gastroenterol. 2016 Oct;7(4):301-307. doi: 10.1136/flgastro-2015-100681. Epub 2016 Apr 7. Frontline Gastroenterol. 2016. PMID: 28839871 Free PMC article. Review.
-
Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1.Exp Mol Med. 2021 Jan;53(1):19-29. doi: 10.1038/s12276-021-00555-5. Epub 2021 Jan 21. Exp Mol Med. 2021. PMID: 33479411 Free PMC article. Review.
-
Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis.Inflamm Bowel Dis. 2012 May;18(5):955-67. doi: 10.1002/ibd.21867. Epub 2011 Sep 26. Inflamm Bowel Dis. 2012. PMID: 21953855 Free PMC article.
-
Azathioprine reduces extravasation and neutrophil trafficking in immune complex-mediated inflammation in the rat colon.Agents Actions. 1991 Sep;34(1-2):244-6. doi: 10.1007/BF01993293. Agents Actions. 1991. PMID: 1665297
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical